Article Data

  • Views 1386
  • Dowloads 163

Reviews

Open Access

Omentectomy in endometrial cancer: an evidence-based insight

  • M.R. Brincat1,*,
  • Y. Muscat Baron2
  • E. Borg3

1Department of Obstetrics and Gynaecology,Malta

2 Mater Dei Hospital, Malta

3Gwardamangia ,Malta

DOI: 10.12892/ejgo3714.2017 Vol.38,Issue 4,August 2017 pp.511-515

Published: 10 August 2017

*Corresponding Author(s): M.R. Brincat E-mail: mark.a.brincat@gov.mt

Abstract

Omentectomy is the surgical removal of the omentum. It is a routine component of staging surgery for confirmed or suspected ovarian carcinoma; however there is currently no consensus regarding omentectomy in surgery performed for endometrial cancer. Additionally, the extent of omental resection in patients without macroscopic deposits is unclear. A systematic search of PubMed MEDLINE resources was performed using the MeSH terms ‘endometrium’ ‘uterus’ ‘omentum’ ‘surgery’ ‘neoplasms’, and ‘neoplasm metastasis’. The authors conducted a literature review of articles published through January 2016 to summarize the current evidence analyzing omental assessment in endometrial cancer and the repercussions its involvement could have on patient management and prognosis. Metastasis to the omentum is a significant finding in endometrial cancer cases as it indicates upstaging to Stage IV-B (FIGO 2009). Assessment for omental spread helps indicate whether neoplastic deposits are spread beyond the conventional radiotherapy field and assist decision-taking with regards to platinum therapy. Macroscopic assessment of the omentum at the time of abdominal surgery for endometrial carcinoma has been shown to be highly sensitive and specific, and thus advisable. Omental biopsies and histopathological examination are more likely to affect management planning in cases at high-risk of upstaging, these being poorly differentiated tumors (Grade 2 and above), non-endometroid cytologies, cases with > 50% myometrial invasion, or cervical or adnexal involvement of the tumor. Total omentectomy and thorough histological assessment is superior with regards to detection of neoplastic spread however presents a significant strain on hospital laboratory services. Maximal surgical cytoreduction including omentectomy has been shown to improve overall survival in Stage 3 or 4 patients with good performance status.

Keywords

Ovarian carcinoma; Omentum; Endometrial cancer; Evidence-based study.

Cite and Share

M.R. Brincat,Y. Muscat Baron,E. Borg. Omentectomy in endometrial cancer: an evidence-based insight. European Journal of Gynaecological Oncology. 2017. 38(4);511-515.

References

[1] Cancer Research UK: “Data Table: Cancer incidence rates in the UK”. Available at: http://publications.cancerresearchuk.org/cancerstats/statsincidence/dtincrates.html

[2] Amant F., Moerman P., Neven P., Timmerman D., Van Limbergen E., Vergote I.: “Endometrial cancer”. Lancet, 2005, 366, 491.

[3] Cancer Research UK: “Uterine cancer statistics”. Available at: http://www.cancerresearchuk.org/health-professional/cancerstatistics/statistics-by-cancer-type/uterine-cancer

[4] Cancer Research UK: Cancer of the body of the uterus (C54): 2006- 2010”. Available at: http://www.cancerresearchuk.org/sites/default/ files/cstream-node/surv_1yr_stage_w_uterus.pdf

[5] Howlader N., Noone A.M., Krapcho M., Garshell J., Miller D., Altekruse S..F, et al. (eds): “SEER Cancer Statistics Review, 1975- 2012” Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/archive/csr/1975_2012/

[6] Cancer Research UK: “Cancer of the Body of the Uterus (C54): 2002-2006” Available at: http://www.cancerresearchuk.org/sites/default/files/cstream-node/surv_5yr_stage_w_uterus.pdf

[7] Mendivil A., Schuler K.M., Gehrig P.A.: “Non-endometrioid adenocarcinoma of the uterine corpus: a review of selected histological subtypes”. Cancer Control, 2009, 16, 46.

[8] Haltia U.M., Bützow R., Leminen A., Loukovaara M.: “FIGO 1988 versus 2009 staging for endometrial carcinoma: a comparative study on prediction of survival and stage distribution according to histologic subtype”. J. Gynecol. Oncol., 2014, 25, 30.

[9] Hamilton C.A., Cheung M.K., Osann K., Chen L., Teng N.N., Longacre T.A., et al.: “Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers”. Br. J. Cancer, 2006, 94, 642.

[10] Creasman W.T., Morrow C.P., Bundy B.N., Homesley H.D., Graham J.E., Heller P.B.: “Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study”. Cancer, 1987, 60, 2035.

[11] Freij M.A., Burbos N., Mukhopadhyay D., Lonsdale R., Crocker S., Nietto J.J.: “The role of omental biopsy in endometrial cancer staging”. Gynecol. Surg., 2009, 6, 215.

[12] Klopp A.H., Zhang Y., Solley T., Amaya-Manzanares F., Marini F., Andreeff M., et al.: “Omental adipose tissue-derived stromal cells promote vascularization and growth of endometrial tumors”.Clin. Cancer Res., 2012, 18, 771.

[13] Benedet JL., Bender H., Jones H.I., Ngan H.Y., Pecorelli S.: “FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology”. Int. J. Gynaecol. Obstet., 2000, 70, 209.

[14] Ben-Shachar I., Pavelka J., Cohn D.E., Copeland L.J., Ramirez N., Manolitsas T., Fowler J.M.: “Surgical staging for patients presenting with grade 1 endometrial carcinoma”. Obstet. Gynecol., 2005, 105, 487.

[15] Dilek S., Dilek U., Dede M., Deveci M.S., Yenen M.C.: “The role of omentectomy and appendectomy during the surgical staging of clinical stage I endometrial cancer”. Int. J. Gynecol. Cancer, 2006, 16, 795.

[16] Fujiwara H., Saga Y., Takahashi K., Ohwada M., Enomoto A., Konno R., et al.: “Omental metastases in clinical stage I endometrioid adenocarcinoma”. Int. J. Gynecol. Cancer, 2008, 18, 165.

[17] ASTEC study group, Kitchener H., Swart A.M., Qian Q., Amos C., Parmar M.K.: “Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study”. Lancet, 2009, 373, 125.

[18] Kim D., Lee J., Kim W.: “A comparison of total versus partial omentectomy for advanced gastric cancer in laparoscopic gastrectomy”. World J. Surg. Oncol., 2014, 12, 64.

[19] Ariake K., Yokoyama S., Doi T., Takemura S., Kajiwara T., Kuroda F.: “Effect of omentum removal on the risk for postoperative adhesive small bowel obstruction recurrence: a case-control study”. Int. J. Surg., 2015, 13, 27.

[20] Dilek S., Dilek U., Dede M., Deveci M.S., Yenen M.C.: “The role of omentectomy and appendectomy during the surgical staging of clinical stage I endometrial cancer”. Int. J. Gynecol. Cancer, 2006, 16, 795.

[21] Usubütün A., Ozseker H.S., Himmetoglu C., Balci S., Ayhan A.: “Omentectomy for gynecologic cancer: How much sampling is adequate for microscopic examination?” Arch. Pathol. Lab. Med., 2007, 131, 1578.

[22] Fujiwara H., Saga Y., Takahashi K., Ohwada M., Enomoto A., Konno R., et al.: “Omental metastases in clinical stage I endometrioid adenocarcinoma”. Int. J. Gynecol. Cancer, 2008, 18, 165.

[23] Freij M.A., Burbos N., Mukhopadhyay D., Lonsdale R., Crocker S., Nietto J.J.: “The role of omental biopsy in endometrial cancer staging”. Gynecol. Surg., 2009, 6, 215.

[24] Metindir J., Dilek G.B.: “The role of omentectomy during the surgical staging in patients with clinical stage I endometrioid adenocarcinoma”. J. Cancer Res. Clin. Oncol., 2008, 134, 1067.

[25] Saygili U., Kavaz S., Altunyurt S., Uslu T., Koyuncuoglu M., Erten O.: “Omentectomy, peritoneal biopsy and appendectomy in patients with clinical stage I endometrial carcinoma”. Int. J. Gynecol. Cancer, 2001, 11, 471.

[26] Nieto J.J., Gornall R., Toms E., Clarkson S., Hogston P., Woolas R.P.: “Influence of omental biopsy on adjuvant treatment field in clinical Stage I endometrial carcinoma”. BJOG, 2002, 109, 576.

[27] Chen S.S., Spiegel G.: “Stage I endometrial carcinoma. Role of omental biopsy and omentectomy”. J. Reprod. Med., 1991, 36, 627.

[28] Saygili U., Kavaz S., Altunyurt S., Uslu T., Koyuncuoglu M., Erten O.: “Omentectomy, peritoneal biopsy and appendectomy in patients with clinical stage I endometrial carcinoma”. Int. J. Gynecol. Cancer, 2001, 11, 471.

[29] Eto T., Saito T., Kasamatsu T., Nakanishi T., Yokota H., Satoh T., et al.: “Clinicopathological prognostic factors and the role of cytoreduction in surgical stage IVb endometrial cancer: a retrospective multi-institutional analysis of 248 patients in Japan”. Gynecol. Oncol., 2012, 127, 338.

[30] Fujiwara H., Saga Y., Takahashi K., Ohwada M., Enomoto A., Konno R., et al.: “Omental metastases in clinical stage I endometrioid adenocarcinoma”. Int. J. Gynecol. Cancer, 2008, 18, 165.

[31] Cirisano F., Robboy S., Dodge R., Bentley R., Krigman H., Synan I., et al.: “Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma”. Gynecol. Oncol., 1999, 74, 385.

[32] Kato D., Ferry J., Goodman A., Sullinger J., Scully R., Goff B., et al.: “Uterine papillary serous carcinoma (UPSC): a clinicopathologic study of 30 cases”. Gynecol. Oncol., 1995, 59, 384.

[33] Geisler J., Geisler H., Melton M., Wiemann M.: “What staging surgery should be performed on patients with uterine papillary serous carcinoma?” Gynecol. Oncol., 1999, 74, 465.

[34] Usubütün A., Ozseker H.S., Himmetoglu C., Balci S., Ayhan A.: “Omentectomy for gynecologic cancer: how much sampling is adequate for microscopic examination?” Arch. Pathol. Lab. Med., 2007, 131, 1578.

[35] Doig T., Monaghan H.: “Sampling the omentum in ovarian neoplasia: when one block is enough”. Int. J. Gynecol. Cancer, 2006, 16, 36.

[36] Chen S.: “Extrauterine spread in endometrial carcinoma clinically confined to the uterus”. Gynecol. Oncol., 1985, 21, 23.

[37] Gehrig P.A., Van Le L., Fowler W.C. Jr.: “The role of omentectomy during the surgical staging of uterine serous carcinoma”. Int. J. Gynecol. Cancer, 2003, 13, 212.

[38] Turan T., Ureyen I., Karalok A., Tasci T., Ilgin H., Keskin L., et al.: “What is the importance of omental metastasis in patients with endometrial cancer?” J. Turk. Ger. Gynecol. Assoc., 2014, 15, 164.

[39] Nieto J.: “Influence of omental biopsy on adjuvant treatment field in clinical Stage I endometrial carcinoma”. BJOG, 2002, 109, 576.

[40] Joo W., Schwartz P., Rutherford T., Seong S., Ku J., Park H., et al.: “Microscopic omental metastasis in clinical Stage I endometrial cancer: a meta-analysis”. Ann. Surg. Oncol., 2015, 22, 3695.

[41] Joint SOGC-GOC-SCC Clinical Practice Guideline No. 289: “The role of surgery in endometrial cancer”. Available at: http://sogc.org/ wp-content/uploads/2013/07/gui289CPG1304E.pdf

[42] Ueda M.S., Bristow E.R.: “Cytoreductive surgery in endometrial cancer and uterine sarcomas”. In: Yildirim Y. (ed). Cytoreductive surgery in gynecologic oncology: a multidisciplinary approach. 2010, 123. Available at: http://www.trnres.com/ebook/uploads/ yildirim/T_1273558229Yildirim-7.pdf

[43] Bristow R., Zerbe M., Rosenshein N., Grumbine F., Montz F.: “Stage IVB endometrial carcinoma: the role of cytoreductive surgery and determinants of survival”. Gynecol. Oncol., 2000, 78, 85.


Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top